• 594 Citations
  • 14 h-Index
1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Biography

Associate Professor Bryone Kuss is the academic head of Molecular Medicine (Haematology and Molecular Genetics) for Flinders University and the clinical head of Molecular Genetics at SA Pathology at Flinders Medical Centre. She is a senior consultant haematologist qualifying in 1993. She obtained a PhD in molecular genetics from Adelaide University in 1997 and has been a recipient of Fellowships from the NHMRC, Royal Society of London and RACP for the study of molecular mechanisms in leukaemia.

Bryone is co-coordinator of Knowledge of Health and Illness for the year 1 Graduate Entry Medical Programme and tutors in haematology and molecular genetics courses for Flinders University.

Research Interests

Her current research interests include exploring mechanisms of drug resistance and studying prognostic factors in chronic lymphocytic leukaemia (CLL) in collaboration with Associate Professor Peter Macardle, Head of the Flow Cytometry Facility, FMC with PhD and Honours programmes offered. She is a founding member of the CLL Australian Research Consortium and provides central diagnostic testing for this group in clinical trials.

Her aims are to ensure a state-of-the-art diagnostic facility for patients suffering with CLL and lymphoma, and to provide ongoing research in these diseases.

Fingerprint Dive into the research topics where Bryone Kuss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study

Davids, M. S., Kuss, B., Hillmen, P., Montillo, M., Moreno, C., Essell, J., Lamanna, N., Nagy, Z., Tam, C. S., Stilgenbauer, S., Ghia, P., Delgado, J., Lustgarten, S., Weaver, D., Youssoufian, H. & Jager, U., 1 May 2020, In : Clinical Cancer Research. 26, 9, p. 2096-2103 8 p.

Research output: Contribution to journalArticle

  • 2 Citations (Scopus)

    Warming blood prior to transfusion using latent heat

    Roxby, D., Sobieraj-Teague, M., von Wielligh, J., Sinha, R., Kuss, B., Smith, A. L. & McEwen, M., 1 Aug 2020, In : EMA - Emergency Medicine Australasia. 32, 4, p. 604-610 7 p.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Results from the MRD Cohort of the Phase 2 CAPTIVATE Study

    Tam, C. S., Siddiqi, T., Allan, J. N., Kipps, T. J., Flinn, I. W., Kuss, B., Opat, S., Barr, P. M., Tedeschi, A., Jacobs, R., Badoux, X. C., Ghia, P., Sukbuntherng, J., Salem, A. H., Russell, K., Eckert, K., Zhou, C., Ninomoto, J., James, D. F. & Wierda, W. G., 13 Nov 2019, In : Blood. 134, 1, 1 p.

    Research output: Contribution to journalArticle

  • Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

    Younes, A., Brody, J., Carpio, C., Lopez-Guillermo, A., Ben-Yehuda, D., Ferhanoglu, B., Nagler, A., Ozcan, M., Avivi, I., Bosch, F., Caballero Barrigon, M. D., Hellmann, A., Kuss, B., Ma, D., Demirkan, F., Yağci, M., Horowitz, N., Marlton, P., Cordoba, R., Wrobe, T. & 11 others, Buglio, D., Streit, M., Hodkinson, B., Schaffer, M., Alvarez, J., Ceulemans, R., Balasubramanian, S., de Jong, J., Wang, S-S., Fourneau, N. & Jurczak, W., Feb 2019, In : The Lancet Haematology. 6, 2, p. e67-e78 12 p.

    Research output: Contribution to journalArticle

  • 40 Citations (Scopus)